Neuroscience
Breakthrough Pill Boosts Stroke Brain Recovery
September 15, 2025 በAI የተዘገበ
Researchers have developed a pill that stimulates brain regeneration for stroke recovery by promoting neurogenesis and repairing damage. Tested in preclinical models, the drug replicates rehabilitation effects without extensive therapy. This innovation offers new hope for stroke patients worldwide.
Playing musical instruments boosts children's reading skills
A new study reveals that children who learn to play musical instruments show significant improvements in reading abilities. The research highlights how musical training enhances phonological awareness, a key component of literacy development. These findings suggest potential benefits for integrating music education in schools.
Human Studies Expand on Transcranial Ultrasound
New human studies on transcranial focused ultrasound (tFUS) demonstrated its ability to alter perception, mood, and decision-making, with expansions reported on September 9, 2025.
CRISPR Tool Targets Neuron Gene Repair
September 15, 2025 በAI የተዘገበ
Stanford researchers have created a CRISPR-based technology to target RNA in neurons, enabling repair processes for genetic diseases. The method addresses key challenges in Cas9 delivery and DNA repair. It reveals unique genome editing rules in neurons, paving the way for targeted therapies.
Scientists discover protein that switches off hunger
Researchers have identified how a protein called MRAP2 regulates hunger by transporting the brain receptor MC4R to the cell surface, enhancing appetite-suppressing signals. This finding, from a study involving institutions in Germany, Canada, and the UK, could lead to new obesity treatments. The work was published in Nature Communications.
DMT reduces stroke damage in animal and cell studies
Researchers in Hungary have found that DMT, a natural psychoactive compound, significantly mitigates brain damage from stroke in animal models and cell cultures. The molecule restores the blood-brain barrier and curbs inflammation, potentially complementing current treatments. These discoveries, published in Science Advances, highlight DMT's therapeutic promise amid limited stroke options.
Cellular switch discovery offers hope for Parkinson's treatment
Scientists have identified a key cellular regulator called PP2A-B55alpha that balances mitochondrial health, potentially leading to new therapies for Parkinson's disease. In preclinical models, reducing its activity improved motor symptoms and mitochondrial function. The findings, published in Science Advances, could extend to other mitochondrial disorders and cancer.
Glioblastoma erodes skull and disrupts immune system, study reveals
Researchers have discovered that glioblastoma, the most aggressive form of brain cancer, extends beyond the brain by eroding the skull and altering the immune cells in skull marrow. This interaction fuels the cancer's progression and explains why current treatments often fail. The findings, published in Nature Neuroscience, suggest new strategies targeting both brain and bone.
Harvard study links gut bacteria to lower anxiety levels
Researchers at Harvard University have identified specific gut microbiome compositions associated with reduced anxiety in humans. The two-year study, published today, strengthens evidence for the gut-brain connection. This discovery opens doors to microbiome-based mental health interventions.
Evolution of human intelligence linked to mental illness vulnerability
Researchers have traced genetic variants in the human genome to reveal that advances in cognitive abilities around 500,000 years ago were soon followed by mutations increasing susceptibility to psychiatric disorders. This suggests a trade-off in brain evolution. The study, published in Cerebral Cortex, analyzed 33,000 genetic variants to build an evolutionary timeline of brain-related traits.